Aarti Pharmalabs Limited (BOM:543748)
India · Delayed Price · Currency is INR 643.65
+21.10 (3.39%)
At close: Jun 4, 2026
Aarti Pharmalabs Revenue
In the fiscal year ending March 31, 2026, Aarti Pharmalabs had annual revenue of 18.19B INR, down -13.98%. Aarti Pharmalabs had revenue of 5.83B in the quarter ending March 31, 2026, with 3.35% growth.
Revenue
18.19B
Revenue Growth
-13.98%
P/S Ratio
3.13
Revenue / Employee
8.42M
Employees
2,162
Market Cap
56.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 18.19B | -2.96B | -13.98% |
| Mar 31, 2025 | 21.15B | 2.62B | 14.17% |
| Mar 31, 2024 | 18.53B | -926.24M | -4.76% |
| Mar 31, 2023 | 19.45B | 7.45B | 62.11% |
| Mar 31, 2022 | 12.00B | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Viyash Scientific | 34.20B |
| Unichem Laboratories | 22.65B |
| FDC Limited | 21.71B |
| Morepen Laboratories | 18.06B |
| Sanofi India | 17.74B |
| Procter & Gamble Health | 14.08B |
| CORONA Remedies | 14.03B |
| Gufic Biosciences | 9.47B |